| CAT | AP5072264-B |
| CAS | 5072-26-4 |
| Structure: |  |
| MDL Number | MFCD00070309 |
| Molecular Weight | 222.31 |
| InChI Key | KJQFBVYMGADDTQ-UHFFFAOYSA-N |
| REAXYS Number | 2367136 |
| Description | ≥99.0% (TLC) |
| Size | 250MG, 1G, 5G |
| Assay | ≥99.0% (TLC) |
| Solubility | H2O: 50 mg/mL, clear to almost clear, colorless |
| Storage Conditions | 2-8°C |
1Augmentation of Cisplatin (DDP) Cytotoxicity in Vivo by DL-buthionine Sulfoximine (BSO) in DDP-sensitive And-Resistant Rat Ovarian Tumors and Its Relation to DNA Interstrand Cross Links
G Chen, W J Zeller
Anticancer Res. Nov-Dec 1991;11(6):2231-7.
PMID: 1776864
1Depletion of Brain Glutathione in Preweanling Mice by L-buthionine Sulfoximine
A Slivka, M B Spina, H I Calvin, G Cohen
J Neurochem. 1988 May;50(5):1391-3.
PMID: 3361302
1Hepatotoxicity of Eugenol in Mice Depleted of Glutathione by Treatment With DL-buthionine Sulfoximine
T Mizutani, K Satoh, H Nomura, K Nakanishi
Res Commun Chem Pathol Pharmacol. 1991 Feb;71(2):219-30.
PMID: 2047567
1p-Dichlorobenzene-induced Hepatotoxicity in Mice Depleted of Glutathione by Treatment With Buthionine Sulfoximine
T Mizutani, Y Nakahori, K Yamamoto
Toxicology. Nov-Dec 1994;94(1-3):57-67.
PMID: 7801330
1Simultaneous Inhibition of Renal Phospholipase A(2) and Glutathione Synthesis by Manoalide and DL-buthionine Sulfoximine Induces Acute Tubular Dysfunction in Rats
A Soejima, S Ishizuka, N Miyake, K Fukuoka, M Suzuki, Y Kamiya, T Nagasawa
Exp Nephrol. Mar-Apr 2000;8(2):84-90.
PMID: 10729747
or fill out the following form.